Logo image of NMAX

NEWSMAX INC (NMAX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:NMAX - US65250K1051 - Common Stock

8.67 USD
-0.2 (-2.25%)
Last: 12/26/2025, 8:05:55 PM
8.9072 USD
+0.24 (+2.74%)
After Hours: 12/26/2025, 8:05:55 PM
Fundamental Rating

3

Overall NMAX gets a fundamental rating of 3 out of 10. We evaluated NMAX against 94 industry peers in the Media industry. No worries on liquidiy or solvency for NMAX as it has an excellent financial health rating, but there are worries on the profitability. NMAX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NMAX has reported negative net income.
NMAX Yearly Net Income VS EBIT VS OCF VS FCFNMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of NMAX (-77.73%) is worse than 84.04% of its industry peers.
NMAX has a worse Return On Equity (-171.17%) than 73.40% of its industry peers.
Industry RankSector Rank
ROA -77.73%
ROE -171.17%
ROIC N/A
ROA(3y)-53.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NMAX Yearly ROA, ROE, ROICNMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 200 -200 400 600 800

1.3 Margins

The Gross Margin of NMAX (45.23%) is comparable to the rest of the industry.
NMAX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NMAX Yearly Profit, Operating, Gross MarginsNMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40

More info and screens

7

2. Health

2.1 Basic Checks

NMAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NMAX has about the same amount of shares outstanding.
NMAX has a better debt/assets ratio than last year.
NMAX Yearly Shares OutstandingNMAX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
NMAX Yearly Total Debt VS Total AssetsNMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M

2.2 Solvency

NMAX has an Altman-Z score of 3.06. This indicates that NMAX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NMAX (3.06) is better than 81.91% of its industry peers.
NMAX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NMAX (0.00) is better than 88.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.06
ROIC/WACCN/A
WACC8.79%
NMAX Yearly LT Debt VS Equity VS FCFNMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -20M -40M

2.3 Liquidity

NMAX has a Current Ratio of 2.74. This indicates that NMAX is financially healthy and has no problem in meeting its short term obligations.
NMAX has a better Current ratio (2.74) than 88.30% of its industry peers.
NMAX has a Quick Ratio of 2.71. This indicates that NMAX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.71, NMAX belongs to the top of the industry, outperforming 88.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 2.71
NMAX Yearly Current Assets VS Current LiabilitesNMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

NMAX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.55%.
NMAX shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.42%.
EPS 1Y (TTM)-68.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)26.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NMAX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.73% yearly.
Based on estimates for the next years, NMAX will show a quite strong growth in Revenue. The Revenue will grow by 13.51% on average per year.
EPS Next Y-77.75%
EPS Next 2Y38.8%
EPS Next 3Y27.18%
EPS Next 5Y21.73%
Revenue Next Year7.53%
Revenue Next 2Y10.86%
Revenue Next 3Y11.35%
Revenue Next 5Y13.51%

3.3 Evolution

NMAX Yearly Revenue VS EstimatesNMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
NMAX Yearly EPS VS EstimatesNMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NMAX. In the last year negative earnings were reported.
Also next year NMAX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NMAX Price Earnings VS Forward Price EarningsNMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NMAX Per share dataNMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

NMAX's earnings are expected to grow with 27.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.8%
EPS Next 3Y27.18%

More info and screens

0

5. Dividend

5.1 Amount

NMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

NEWSMAX INC

NYSE:NMAX (12/26/2025, 8:05:55 PM)

After market: 8.9072 +0.24 (+2.74%)

8.67

-0.2 (-2.25%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-30 2026-03-30
Inst Owners29.39%
Inst Owner Change20.49%
Ins OwnersN/A
Ins Owner Change0%
Market Cap1.12B
Revenue(TTM)308.03M
Net Income(TTM)-181.37M
Analysts82.5
Price Target21.42 (147.06%)
Short Float %3.52%
Short Ratio2.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1367.09%
Min EPS beat(2)-2792.16%
Max EPS beat(2)57.98%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.16%
Min Revenue beat(2)0.92%
Max Revenue beat(2)1.4%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.33%
PT rev (3m)-2.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-50.34%
EPS NY rev (3m)-373.91%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.63
P/FCF N/A
P/OCF N/A
P/B 10.57
P/tB 10.57
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.39
BVpS0.82
TBVpS0.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -77.73%
ROE -171.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.23%
FCFM N/A
ROA(3y)-53.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.74
Quick Ratio 2.71
Altman-Z 3.06
F-ScoreN/A
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)90.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.87%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-77.75%
EPS Next 2Y38.8%
EPS Next 3Y27.18%
EPS Next 5Y21.73%
Revenue 1Y (TTM)26.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year7.53%
Revenue Next 2Y10.86%
Revenue Next 3Y11.35%
Revenue Next 5Y13.51%
EBIT growth 1Y-229.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.1%
EBIT Next 3Y28.87%
EBIT Next 5Y25.53%
FCF growth 1Y-946.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1170.71%
OCF growth 3YN/A
OCF growth 5YN/A

NEWSMAX INC / NMAX FAQ

Can you provide the ChartMill fundamental rating for NEWSMAX INC?

ChartMill assigns a fundamental rating of 3 / 10 to NMAX.


What is the valuation status for NMAX stock?

ChartMill assigns a valuation rating of 1 / 10 to NEWSMAX INC (NMAX). This can be considered as Overvalued.


What is the profitability of NMAX stock?

NEWSMAX INC (NMAX) has a profitability rating of 0 / 10.


How financially healthy is NEWSMAX INC?

The financial health rating of NEWSMAX INC (NMAX) is 7 / 10.